Found: 110
Select item for more details and to access through your institution.
MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Editorial: Multidimensionally decoding the impact of tumor heterogeneity on immunotherapy responsiveness in gastrointestinal tumors.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1482206
- By:
- Publication type:
- Article
High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12916-0
- By:
- Publication type:
- Article
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 9, p. 2080, doi. 10.1038/s44321-024-00105-2
- By:
- Publication type:
- Article
Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy.
- Published in:
- Biomarker Research, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40364-024-00630-9
- By:
- Publication type:
- Article
Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Editorial: The role of multi-omics variants in tumor immunity and immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1098825
- By:
- Publication type:
- Article
Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1007461
- By:
- Publication type:
- Article
Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.907182
- By:
- Publication type:
- Article
Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.992855
- By:
- Publication type:
- Article
Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.949490
- By:
- Publication type:
- Article
Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2022.914001
- By:
- Publication type:
- Article
Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.881722
- By:
- Publication type:
- Article
A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.831542
- By:
- Publication type:
- Article
Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.936606
- By:
- Publication type:
- Article
CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.964190
- By:
- Publication type:
- Article
LncRNA profiles from Notch signaling: Implications for clinical management and tumor microenvironment of colorectal cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.953405
- By:
- Publication type:
- Article
Liquid Biopsy in Pre-Metastatic Niche: From Molecular Mechanism to Clinical Application.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.958360
- By:
- Publication type:
- Article
JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.875786
- By:
- Publication type:
- Article
SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.873871
- By:
- Publication type:
- Article
ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.910582
- By:
- Publication type:
- Article
Transcriptome-Based Dissection of Intracranial Aneurysms Unveils an "Immuno-Thermal" Microenvironment and Defines a Pathological Feature-Derived Gene Signature for Risk Estimation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.878195
- By:
- Publication type:
- Article
Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.810471
- By:
- Publication type:
- Article
Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.833792
- By:
- Publication type:
- Article
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.828330
- By:
- Publication type:
- Article
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 4, p. 1, doi. 10.1038/s41419-023-05753-9
- By:
- Publication type:
- Article
Ferroptosis: a double-edged sword mediating immune tolerance of cancer.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05384-6
- By:
- Publication type:
- Article
CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11131-7
- By:
- Publication type:
- Article
Single-cell RNA sequencing integrated with bulk RNA sequencing analysis identifies a tumor immune microenvironment-related lncRNA signature in lung adenocarcinoma.
- Published in:
- BMC Biology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12915-024-01866-5
- By:
- Publication type:
- Article
Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.632430
- By:
- Publication type:
- Article
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, p. N.PAG, doi. 10.3389/fonc.2021.619242
- By:
- Publication type:
- Article
An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.
- Published in:
- Cell Proliferation, 2023, v. 56, n. 4, p. 1, doi. 10.1111/cpr.13409
- By:
- Publication type:
- Article
Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy.
- Published in:
- Cell Proliferation, 2023, v. 56, n. 3, p. 1, doi. 10.1111/cpr.13376
- By:
- Publication type:
- Article
Omics-based molecular classifications empowering in precision oncology.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 3, p. 759, doi. 10.1007/s13402-023-00912-8
- By:
- Publication type:
- Article
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02469-0
- By:
- Publication type:
- Article
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 1877, doi. 10.1038/s41416-023-02442-4
- By:
- Publication type:
- Article
Radiogenomics: a key component of precision cancer medicine.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 5, p. 741, doi. 10.1038/s41416-023-02317-8
- By:
- Publication type:
- Article
Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
- Published in:
- British Journal of Surgery, 2024, v. 111, n. 1, p. 1, doi. 10.1093/bjs/znad377
- By:
- Publication type:
- Article
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05104-y
- By:
- Publication type:
- Article
Tumor buster - where will the CAR-T cell therapy 'missile' go?
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01669-8
- By:
- Publication type:
- Article
PESSA: A web tool for pathway enrichment score-based survival analysis in cancer.
- Published in:
- PLoS Computational Biology, 2024, v. 20, n. 5, p. 1, doi. 10.1371/journal.pcbi.1012024
- By:
- Publication type:
- Article
Immunosenescence: molecular mechanisms and diseases.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01451-2
- By:
- Publication type:
- Article
CPADS: a web tool for comprehensive pancancer analysis of drug sensitivity.
- Published in:
- Briefings in Bioinformatics, 2024, v. 25, n. 3, p. 1, doi. 10.1093/bib/bbae237
- By:
- Publication type:
- Article
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma.
- Published in:
- Briefings in Bioinformatics, 2022, v. 23, n. 6, p. 1, doi. 10.1093/bib/bbac386
- By:
- Publication type:
- Article
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer.
- Published in:
- Briefings in Bioinformatics, 2022, v. 23, n. 3, p. 1, doi. 10.1093/bib/bbac129
- By:
- Publication type:
- Article
B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 7, p. 1, doi. 10.1002/ctm2.1761
- By:
- Publication type:
- Article
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 3, p. 1, doi. 10.1002/ctm2.1620
- By:
- Publication type:
- Article
Epigenetically regulated gene expression profiles recognized three molecular classifications with prognostic and therapeutic implications in bladder cancer.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 3, p. 1, doi. 10.1002/ctm2.1145
- By:
- Publication type:
- Article
Implications of pseudogenes for the prognosis of hepatocellular carcinoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 2, p. 1, doi. 10.1002/ctm2.1195
- By:
- Publication type:
- Article